Answers are grounded in this paper and cite their sources.
Heterosexual transmission of HIV is rising in the US but male-to-male sex and IV drug use still are the major modes of HIV transmission. In developing countries heterosexual transmission has always been responsible for the majority of HIV cases. The new HIV infection rate in the US is increasing quickly among youth ethnic minorities and the urban poor. 90% of new HIV infection cases are in developing countries. If current trends continue the new HIV infection rate will stabilize in developed countries. Research must focus on studying the unique aspects of the HIV epidemic among the populations now at most risk of HIV understanding the determinants of high risk behaviors and adverse consequences of HIV infection in these groups assessing strategies for reducing their exposure to HIV and helping people and societies in managing the effects of HIV infection. Research and model programs should identify the best ways to make sure that behavioral and social science interacts closely with HIV prevention and care services e.g. US President Clintons HIV Prevention Community Planning Councils. The Center for AIDS Prevention Studies at the University of California San Francisco has conducted research worldwide examining determinants of HIV risk for women cultural determinants of high-risk behavior among Latinos and structural and environmental determinants of risk. There have been trials of innovative interventions among young gay men (the interplay between basic science and these interventions) pre-sexually active adolescents heterosexuals in central Africa (HIV prevention) and commercial sex workers in Bombay India. One particular innovative intervention is coping effectiveness training. Ethical issues facing HIV behavioral science services and policies revolve around HIV testing assisted suicide and euthanasia and HIV prophylactic vaccine trials. Most obstacles to effective HIV prevention and care are in policy so policy-relevant research is needed. Such areas to study include syringe exchanges HIV prevention as a good investment and repeat negative testers.
No takes yet. Share an insight, caveat, or question.
Coates et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: